Versant Capital Management, Inc
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1735057
PHOENIX, AZ
Position in ADPT
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$10,596
+$10,596 QoQ
Shares Held
124
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 70 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $4,848,853 across 25 Diagnostics & Research names. ADPT ranks #23 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
4,957 | $658,438 | |
| 2 | ILMN |
Illumina, Inc.
|
3,622 | $636,856 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,014 | $533,810 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
1,963 | $445,188 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
2,291 | $442,667 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
858 | $430,166 | |
| 7 | RVTY |
Revvity, Inc.
|
2,280 | $253,672 | |
| 8 | NTRA |
Natera, Inc.
|
779 | $211,459 |
All Filings in ADPT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,596 | 494 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | — | 494 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | — | 610 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | — | 733 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | — | 901 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | — | 332 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | — | 332 | Shares | Sole | 2025-01-03 | |
| 2023-09-30 | — | 71 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | — | 307 | Shares | Sole | 2023-07-10 | |
| No filing history on record for this holder in this stock. | ||||||